Clinical Trial Update: Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) [NA]

View source ↗

Summary

A clinical trial update describes a study evaluating the role of vitagliptin and vitamin D in treating non-alcoholic fatty liver disease, with the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Vitagliptin (Vitagliptin)
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Ziv Hospital | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: UNKNOWN